P49841 |
GSK3B_HUMAN |
Myotonic disorder [ICD-11: 8C71] |
P49841 |
GSK3B_HUMAN |
Acute myeloid leukaemia [ICD-11: 2A60] |
P49841 |
GSK3B_HUMAN |
Fragile X chromosome [ICD-11: LD55] |
P49841 |
GSK3B_HUMAN |
Myeloproliferative neoplasm [ICD-11: 2A20] |
P49841 |
GSK3B_HUMAN |
Osteosarcoma [ICD-11: 2B51] |
P49841 |
GSK3B_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P49841 |
GSK3B_HUMAN |
Parkinsonism [ICD-11: 8A00] |
P49841 |
GSK3B_HUMAN |
Allergic/hypersensitivity disorder [ICD-11: 4A80-4A8Z] |
P49841 |
GSK3B_HUMAN |
Brain cancer [ICD-11: 2A00] |
P49841 |
GSK3B_HUMAN |
Ovarian cancer [ICD-11: 2C73] |
P49841 |
GSK3B_HUMAN |
Transplant rejection [ICD-11: NE84] |
P49841 |
GSK3B_HUMAN |
Alzheimer disease [ICD-11: 8A20] |
P49841 |
GSK3B_HUMAN |
Acute diabete complication [ICD-11: 5A2Y] |